Mark R. Edbrooke

1.9k total citations
29 papers, 1.5k citations indexed

About

Mark R. Edbrooke is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Mark R. Edbrooke has authored 29 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Genetics. Recurrent topics in Mark R. Edbrooke's work include Glycosylation and Glycoproteins Research (6 papers), RNA Interference and Gene Delivery (5 papers) and Neuropeptides and Animal Physiology (4 papers). Mark R. Edbrooke is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), RNA Interference and Gene Delivery (5 papers) and Neuropeptides and Animal Physiology (4 papers). Mark R. Edbrooke collaborates with scholars based in United Kingdom, United States and Netherlands. Mark R. Edbrooke's co-authors include Patricia Woo, R K Craig, Christopher A. Hewson, Sebastian L. Johnston, John K. Cheshire, Len Hall, Lesley Rawlinson, Luke O'neill, Jeremy Saklatvala and Eleni Stylianou and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Mark R. Edbrooke

29 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark R. Edbrooke United Kingdom 18 963 340 234 197 182 29 1.5k
Rocco J. Rotello United States 11 1.1k 1.1× 497 1.5× 157 0.7× 75 0.4× 243 1.3× 13 1.7k
Siew Heng Wong Singapore 26 1.8k 1.9× 311 0.9× 150 0.6× 242 1.2× 261 1.4× 52 2.6k
Janet Weinstock Australia 20 514 0.5× 265 0.8× 253 1.1× 146 0.7× 334 1.8× 35 1.3k
Hiroko Takeuchi Japan 23 405 0.4× 540 1.6× 350 1.5× 163 0.8× 170 0.9× 57 1.6k
Dalila Darmoul France 24 870 0.9× 273 0.8× 346 1.5× 248 1.3× 574 3.2× 43 2.2k
Kazuyoshi Ueno Japan 13 1.3k 1.4× 339 1.0× 132 0.6× 86 0.4× 343 1.9× 34 1.9k
Roger Vassy France 21 824 0.9× 216 0.6× 225 1.0× 71 0.4× 321 1.8× 51 1.5k
James A. Mahoney United States 14 848 0.9× 745 2.2× 147 0.6× 74 0.4× 139 0.8× 22 1.8k
Frédérique Gaits‐Iacovoni France 30 1.5k 1.5× 277 0.8× 84 0.4× 142 0.7× 126 0.7× 58 2.3k
Masataka Horiuchi Japan 19 689 0.7× 550 1.6× 132 0.6× 95 0.5× 145 0.8× 32 1.4k

Countries citing papers authored by Mark R. Edbrooke

Since Specialization
Citations

This map shows the geographic impact of Mark R. Edbrooke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Edbrooke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Edbrooke more than expected).

Fields of papers citing papers by Mark R. Edbrooke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Edbrooke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Edbrooke. The network helps show where Mark R. Edbrooke may publish in the future.

Co-authorship network of co-authors of Mark R. Edbrooke

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Edbrooke. A scholar is included among the top collaborators of Mark R. Edbrooke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Edbrooke. Mark R. Edbrooke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hunter, Morag R., Aristides D. Tagalakis, Ahmad M. Aldossary, et al.. (2022). Lipid-peptide nanocomplexes for mRNA delivery in vitro and in vivo. Journal of Controlled Release. 348. 786–797. 26 indexed citations
2.
Kamola, Piotr J., Jeremy Kitson, Klio Maratou, et al.. (2015). In silicoandin vitroevaluation of exonic and intronic off-target effects form a critical element of therapeutic ASO gapmer optimization. Nucleic Acids Research. 43(18). 8638–8650. 81 indexed citations
3.
4.
5.
Hewson, Christopher A., Jennifer Haas, Nathan W. Bartlett, et al.. (2010). Rhinovirus induces MUC5AC in a human infection model andin vitroviaNF-κB and EGFR pathways. European Respiratory Journal. 36(6). 1425–1435. 90 indexed citations
6.
Griesenbach, Uta, Chris Kitson, Raymond Farley, et al.. (2006). Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo. Respiratory Research. 7(1). 26–26. 49 indexed citations
7.
Griesenbach, Uta, Chris Kitson, Hazel Painter, et al.. (2004). LacZ siRNA and antisense DNA decrease beta-galactosidase mRNA but not protein expression in the airways of K18-lacZ transgenic mice. The Journal of Gene Medicine. 6(9). 1 indexed citations
8.
Hewson, Christopher A., Mark R. Edbrooke, & Sebastian L. Johnston. (2004). PMA Induces the MUC5AC Respiratory Mucin in Human Bronchial Epithelial Cells, via PKC, EGF/TGF-α, Ras/Raf, MEK, ERK and Sp1-dependent Mechanisms. Journal of Molecular Biology. 344(3). 683–695. 150 indexed citations
9.
Eijnden, Dirk H. van den, William McDowell, Valerie A. Kelly, et al.. (1998). Acceptor specificity of the human leukocyte  3 fucosyltransferase: role of FucT-VII in the generation of selectin ligands. Glycobiology. 8(4). 321–327. 34 indexed citations
10.
Edbrooke, Mark R., et al.. (1997). Lewis X Biosynthesis in Helicobacter pylori. Journal of Biological Chemistry. 272(34). 21349–21356. 104 indexed citations
11.
Edbrooke, Mark R., et al.. (1997). The α(1-3)-fucosyltransferases come of age. Biochemical Society Transactions. 25(3). 880–886. 5 indexed citations
12.
Kelly, Valerie A., et al.. (1997). Expression of a secreted form of human α 1,3 fucosyltransferase VII from insect cells. Biochemical Society Transactions. 25(3). 426S–426S. 6 indexed citations
13.
Goodson, S.J., et al.. (1995). The Human A3 Adenosine Receptor Gene. Biochemical Society Transactions. 23(2). 270S–270S. 5 indexed citations
14.
Winder, Alison J., et al.. (1995). Tissue specific expression of the human α(1–3) fucosyltransferase gene family. Biochemical Society Transactions. 23(2). 165S–165S. 3 indexed citations
15.
Betts, Jonathan C., Mark R. Edbrooke, Rajesh V. Thakker, & Patricia Woo. (1991). The Human Acute‐Phase Serum Amyloid A Gene Family: Structure, Evolution and Expression in Hepatoma Cells. Scandinavian Journal of Immunology. 34(4). 471–482. 80 indexed citations
16.
Edbrooke, Mark R., J. Földi, John K. Cheshire, et al.. (1991). Constitutive and NF-κB—like proteins in the regulation of the serum amyloid a gene by interleukin 1. Cytokine. 3(5). 380–388. 52 indexed citations
17.
Edbrooke, Mark R., David W. Burt, John K. Cheshire, & Patricia Woo. (1989). Identification of cis -Acting Sequences Responsible for Phorbol Ester Induction of Human Serum Amyloid A Gene Expression via a Nuclear Factor κB-Like Transcription Factor. Molecular and Cellular Biology. 9(5). 1908–1916. 5 indexed citations
18.
Riley, John, Mark R. Edbrooke, & R K Craig. (1986). Ectopic synthesis of high‐Mr calcitonin by the BEN lung carcinoma cell line reflects aberrant proteolytic processing. FEBS Letters. 198(1). 71–79. 24 indexed citations
19.
Craig, R K, Mark R. Edbrooke, J. Riley, John H. McVey, & D Parker. (1985). Differential Expression of the Human Calcitonin — CGRP Gene in Medullary Thyroid Carcinoma and Lung Carcinoma Cell Lines. Recent results in cancer research. 99. 71–78. 12 indexed citations
20.
Edbrooke, Mark R., D Parker, John H. McVey, et al.. (1985). Expression of the human calcitonin/CGRP gene in lung and thyroid carcinoma.. The EMBO Journal. 4(3). 715–724. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rocco J. Rotello Breakdown of academic impact, for papers by Siew Heng Wong Breakdown of academic impact, for papers by Janet Weinstock Breakdown of academic impact, for papers by Hiroko Takeuchi Breakdown of academic impact, for papers by Dalila Darmoul Breakdown of academic impact, for papers by Kazuyoshi Ueno Breakdown of academic impact, for papers by Roger Vassy Breakdown of academic impact, for papers by James A. Mahoney Breakdown of academic impact, for papers by Frédérique Gaits‐Iacovoni Breakdown of academic impact, for papers by Masataka Horiuchi
Rankless by CCL
2026